Global Infectious Disease Market 2023-2027

Description

List of Tables

Technavio has been monitoring the infectious disease market and it is poised to grow by $104.81 bn during 2023-2027, accelerating at a CAGR of 12.49% during the forecast period. Our report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of infectious diseases, growing awareness of infectious diseases, and a strong drug pipeline.

Technavio's infectious disease market is segmented as below:

By Product

Drugs
Vaccines

By End-user

Hospital
Multispecialty clinic
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of novel drugs as one of the prime reasons driving the infectious disease market growth during the next few years. Also, increasing mergers and acquisitions and the emergence of new patterns of infectious diseases will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the infectious disease market covers the following areas:

Infectious disease market sizing
Infectious disease market forecast
Infectious disease market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infectious disease market vendors that include Bio Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Trinity Biotech Plc, Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, Quidel Corp., and Thermo Fisher Scientific Inc. Also, the infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR71174

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global infectious disease market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global infectious disease market 2017 - 2021 ($ billion)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Drugs - Year-over-year growth 2022-2027 (%)
6.4 Vaccines - Market size and forecast 2022-2027
Exhibit 38: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by End-user
Exhibit 46: Data Table on Comparison by End-user
7.3 Hospital - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospital - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on Hospital - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
7.4 Multispecialty clinic - Market size and forecast 2022-2027
Exhibit 51: Chart on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 61: Chart on Market share by geography 2022-2027 (%)
Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 101: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 108: Abbott Laboratories - Overview
Exhibit 109: Abbott Laboratories - Business segments
Exhibit 110: Abbott Laboratories - Key news
Exhibit 111: Abbott Laboratories - Key offerings
Exhibit 112: Abbott Laboratories - Segment focus
12.4 Becton Dickinson and Co.
Exhibit 113: Becton Dickinson and Co. - Overview
Exhibit 114: Becton Dickinson and Co. - Business segments
Exhibit 115: Becton Dickinson and Co. - Key news
Exhibit 116: Becton Dickinson and Co. - Key offerings
Exhibit 117: Becton Dickinson and Co. - Segment focus
12.5 Bio Rad Laboratories Inc.
Exhibit 118: Bio Rad Laboratories Inc. - Overview
Exhibit 119: Bio Rad Laboratories Inc. - Business segments
Exhibit 120: Bio Rad Laboratories Inc. - Key news
Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
12.6 bioMerieux SA
Exhibit 123: bioMerieux SA - Overview
Exhibit 124: bioMerieux SA - Product / Service
Exhibit 125: bioMerieux SA - Key offerings
12.7 Danaher Corp.
Exhibit 126: Danaher Corp. - Overview
Exhibit 127: Danaher Corp. - Business segments
Exhibit 128: Danaher Corp. - Key news
Exhibit 129: Danaher Corp. - Key offerings
Exhibit 130: Danaher Corp. - Segment focus
12.8 DiaSorin SpA
Exhibit 131: DiaSorin SpA - Overview
Exhibit 132: DiaSorin SpA - Business segments
Exhibit 133: DiaSorin SpA - Key news
Exhibit 134: DiaSorin SpA - Key offerings
Exhibit 135: DiaSorin SpA - Segment focus
12.9 F. Hoffmann La Roche Ltd.
Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Meridian Bioscience Inc.
Exhibit 141: Meridian Bioscience Inc. - Overview
Exhibit 142: Meridian Bioscience Inc. - Business segments
Exhibit 143: Meridian Bioscience Inc. - Key offerings
Exhibit 144: Meridian Bioscience Inc. - Segment focus
12.11 OraSure Technologies Inc.
Exhibit 145: OraSure Technologies Inc. - Overview
Exhibit 146: OraSure Technologies Inc. - Business segments
Exhibit 147: OraSure Technologies Inc. - Key offerings
Exhibit 148: OraSure Technologies Inc. - Segment focus
12.12 PerkinElmer Inc.
Exhibit 149: PerkinElmer Inc. - Overview
Exhibit 150: PerkinElmer Inc. - Business segments
Exhibit 151: PerkinElmer Inc. - Key news
Exhibit 152: PerkinElmer Inc. - Key offerings
Exhibit 153: PerkinElmer Inc. - Segment focus
12.13 QIAGEN NV
Exhibit 154: QIAGEN NV - Overview
Exhibit 155: QIAGEN NV - Product / Service
Exhibit 156: QIAGEN NV - Key news
Exhibit 157: QIAGEN NV - Key offerings
12.14 Quidel Corp.
Exhibit 158: Quidel Corp. - Overview
Exhibit 159: Quidel Corp. - Product / Service
Exhibit 160: Quidel Corp. - Key offerings
12.15 Siemens AG
Exhibit 161: Siemens AG - Overview
Exhibit 162: Siemens AG - Business segments
Exhibit 163: Siemens AG - Key news
Exhibit 164: Siemens AG - Key offerings
Exhibit 165: Siemens AG - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 166: Thermo Fisher Scientific Inc. - Overview
Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
Exhibit 168: Thermo Fisher Scientific Inc. - Key news
Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
12.17 Trinity Biotech Plc
Exhibit 171: Trinity Biotech Plc - Overview
Exhibit 172: Trinity Biotech Plc - Product / Service
Exhibit 173: Trinity Biotech Plc - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 174: Inclusions checklist
Exhibit 175: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 176: Currency conversion rates for US$
13.4 Research methodology
Exhibit 177: Research methodology
Exhibit 178: Validation techniques employed for market sizing
Exhibit 179: Information sources
13.5 List of abbreviations
Exhibit 180: List of abbreviations